These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30356372)

  • 1. Efficient Synthesis of Glutamate Peptide-Estradiol Conjugate for Imaging Estrogen Receptor-Positive Diseases.
    Shih MC; Simon SD; Jin Z; Gui Y; Xu B; Xu Z; Rosado-de-Castro PH; Silveira Braghirolli AM; Barbosa da Fonseca LM; Inoue T; Yang DJ
    Biomed Res Int; 2018; 2018():5208964. PubMed ID: 30356372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted functional imaging of estrogen receptors with 99mTc-GAP-EDL.
    Takahashi N; Yang DJ; Kohanim S; Oh CS; Yu DF; Azhdarinia A; Kurihara H; Zhang X; Chang JY; Kim EE
    Eur J Nucl Med Mol Imaging; 2007 Mar; 34(3):354-62. PubMed ID: 17021817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional imaging of estrogen receptors with radiolabeled-GAP-EDL in rabbit endometriosis model.
    Takahashi N; Yang DJ; Kurihara H; Borne A; Kohanim S; Oh CS; Mawlawi O; Kim EE
    Acad Radiol; 2007 Sep; 14(9):1050-7. PubMed ID: 17707312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-labeled estradiol as an estrogen receptor probe: Preparation and preclinical evaluation.
    Xia X; Feng H; Li C; Qin C; Song Y; Zhang Y; Lan X
    Nucl Med Biol; 2016 Jan; 43(1):89-96. PubMed ID: 26466867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-Step
    Huang H; Li K; Lv G; Liu G; Zhao X; Liu Q; Wang S; Li X; Qiu L; Lin J
    Contrast Media Mol Imaging; 2018; 2018():5362329. PubMed ID: 29692688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical production, stability studies and PET imaging with 16-alpha-[18F]fluoroestradiol ([18F]FES) in ER positive breast cancer patients.
    Kumar P; Mercer J; Doerkson C; Tonkin K; McEwan AJ
    J Pharm Pharm Sci; 2007; 10(2):256s-265s. PubMed ID: 17718929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Neuropeptide Y1 Receptor for Cancer Imaging by Positron Emission Tomography Using Novel Truncated Peptides.
    Zhang C; Pan J; Lin KS; Dude I; Lau J; Zeisler J; Merkens H; Jenni S; Guérin B; Bénard F
    Mol Pharm; 2016 Nov; 13(11):3657-3664. PubMed ID: 27669056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist (68)Ga-RM2 And PET.
    Stoykow C; Erbes T; Maecke HR; Bulla S; Bartholomä M; Mayer S; Drendel V; Bronsert P; Werner M; Gitsch G; Weber WA; Stickeler E; Meyer PT
    Theranostics; 2016; 6(10):1641-50. PubMed ID: 27446498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
    Mortimer JE; Dehdashti F; Siegel BA; Katzenellenbogen JA; Fracasso P; Welch MJ
    Clin Cancer Res; 1996 Jun; 2(6):933-9. PubMed ID: 9816253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An estradiol-porphyrin conjugate selectively localizes into estrogen receptor-positive breast cancer cells.
    Swamy N; James DA; Mohr SC; Hanson RN; Ray R
    Bioorg Med Chem; 2002 Oct; 10(10):3237-43. PubMed ID: 12150869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In.
    Roosenburg S; Laverman P; Joosten L; Cooper MS; Kolenc-Peitl PK; Foster JM; Hudson C; Leyton J; Burnet J; Oyen WJ; Blower PJ; Mather SJ; Boerman OC; Sosabowski JK
    Mol Pharm; 2014 Nov; 11(11):3930-7. PubMed ID: 24992368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and preliminary evaluation of a PET-FI bimodal imaging agent targeting estrogen receptor.
    Cheng X; Yang Z; Sun Y; Zheng W; Chen H; Liu Y; Wu Z
    Bioorg Med Chem Lett; 2021 Feb; 34():127776. PubMed ID: 33418064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.
    Venema CM; Mammatas LH; Schröder CP; van Kruchten M; Apollonio G; Glaudemans AWJM; Bongaerts AHH; Hoekstra OS; Verheul HMW; Boven E; van der Vegt B; de Vries EFJ; de Vries EGE; Boellaard R; Menke van der Houven van Oordt CW; Hospers GAP
    J Nucl Med; 2017 Dec; 58(12):1906-1912. PubMed ID: 28912144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu/and (68)Ga/NOTA-PEG-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]BBN(6-14).
    Fournier P; Dumulon-Perreault V; Ait-Mohand S; Tremblay S; Bénard F; Lecomte R; Guérin B
    Bioconjug Chem; 2012 Aug; 23(8):1687-93. PubMed ID: 22770480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.
    Saha P; Fortin S; Leblanc V; Parent S; Asselin É; Bérubé G
    Steroids; 2012 Sep; 77(11):1113-22. PubMed ID: 22801351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
    Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
    Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.